Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice (Q34432972)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

title

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

main subject

cytotoxicity

0 references

angiogenesis

1 reference

based on heuristic

inferred from title

tumor angiogenesis

1 reference

based on heuristic

inferred from title

author name string

D Hanahan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

G Bergers

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

E Bergsland

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

published in

Journal of Clinical Investigation

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

volume

105

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

page(s)

1045-1047

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

cites work

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Replication-selective adenoviruses as oncolytic agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

COX-2 inhibitors. A new class of antiangiogenic agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

The Hallmarks of Cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Thalidomide is an inhibitor of angiogenesis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

retrieved

6 July 2018

Long-term continuous 5-fluorouracil infusion in patients with advanced head and neck cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10772648

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenesis is produced by nontoxic doses of vinblastine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10772648

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inefficacy of low-dose continuous oral etoposide in non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10772648

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10772648

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly schedules of docetaxel

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10772648

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1172/JCI9872

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

Fatcat ID

release_nd2tc6kryvg4tbogmvt3p6oooy

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/nd2tc6kryvg4tbogmvt3p6oooy

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

300842

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

PubMed publication ID

10772648

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10772648

retrieved

2 August 2017

ResearchGate publication ID

12543350

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34432972&oldid=1842281865"